Literature DB >> 16138344

Acute lymphoblastic leukemia in a patient with chronic granulomatous disease and a novel mutation in CYBB: first report.

Baruch Wolach1, Shifra Ash, Ronit Gavrieli, Batia Stark, Isaac Yaniv, Dirk Roos.   

Abstract

We report for the first time a child with chronic granulomatous disease (CGD) who developed acute lymphoblastic leukemia (ALL). The diagnosis of CGD was made at the age of 4 months, by studies of his neutrophil functions. The superoxide production of the cells was negligible, as was the bactericidal activity. He was found to have a deficiency of the gp91(phox) subunit of the leukocyte NADPH oxidase, with the X-linked inheritance of the disease. DNA analysis revealed a C nucleotide insertion between C1028 and T1029. This insertion has not been described before and causes a frameshift and a premature stop codon at amino-acid position 347. The mother was found to be a carrier of this mutation. At the age of 16 months, the patient developed T-cell ALL. He was treated for 2 years, and today, 10 years since the diagnosis, he is disease-free. During the course of ALL and later, he suffered from recurrent severe pyogenic infections, but careful detection of the etiological agent and promptly instituted specific treatment resulted in his complete recovery. Although primary immune deficiencies have been reported to have an increased tendency to develop malignancies, until now there have been no reports of CGD patients with ALL. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16138344     DOI: 10.1002/ajh.20424

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  8 in total

Review 1.  Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Joachim Roesler; Juan Alvaro Lopez; Tadashi Ariga; Tadej Avcin; Martin de Boer; Jacinta Bustamante; Antonio Condino-Neto; Gigliola Di Matteo; Jianxin He; Harry R Hill; Steven M Holland; Caroline Kannengiesser; M Yavuz Köker; Irina Kondratenko; Karin van Leeuwen; Harry L Malech; László Marodi; Hiroyuki Nunoi; Marie-José Stasia; Anna Maria Ventura; Carl T Witwer; Baruch Wolach; John I Gallin
Journal:  Blood Cells Mol Dis       Date:  2010-08-21       Impact factor: 3.039

2.  Lessons learned from phagocytic function studies in a large cohort of patients with recurrent infections.

Authors:  Baruch Wolach; Ronit Gavrieli; Dirk Roos; Sivan Berger-Achituv
Journal:  J Clin Immunol       Date:  2011-12-30       Impact factor: 8.317

3.  Hodgkin lymphoma in 2 children with chronic granulomatous disease.

Authors:  Saul Oswaldo Lugo Reyes; Felipe Suarez; Rose-Marie Herbigneaux; Hélène Pacquement; Yves Réguerre; Jean-Pierre Rivière; Maylis de Suremain; Yoann Rose; Jacqueline Feinberg; Nizar Malahoui; Alain Fischer; Stéphane Blanche; Jean-Laurent Casanova; Capucine Picard; Jacinta Bustamante
Journal:  J Allergy Clin Immunol       Date:  2010-12-18       Impact factor: 10.793

4.  Clinical and Immunological Characteristics of 63 Patients with Chronic Granulomatous Disease: Hacettepe Experience.

Authors:  Halil Tuna Akar; Saliha Esenboga; Deniz Cagdas; Sevil Oskay Halacli; Begum Ozbek; Karin van Leeuwen; Martin de Boer; Cagman Sun Tan; Yavuz Köker; Dirk Roos; Ilhan Tezcan
Journal:  J Clin Immunol       Date:  2021-02-24       Impact factor: 8.317

5.  Inherent X-Linked Genetic Variability and Cellular Mosaicism Unique to Females Contribute to Sex-Related Differences in the Innate Immune Response.

Authors:  Zoltan Spolarics; Geber Peña; Yong Qin; Robert J Donnelly; David H Livingston
Journal:  Front Immunol       Date:  2017-11-13       Impact factor: 7.561

Review 6.  Primary Immunodeficiency and Cancer in Children; A Review of the Literature.

Authors:  Rejin Kebudi; Ayca Kiykim; Merve K Sahin
Journal:  Curr Pediatr Rev       Date:  2019

Review 7.  Molecular approaches in the diagnosis of primary immunodeficiency diseases.

Authors:  Maurizio Costabile; Alex Quach; Antonio Ferrante
Journal:  Hum Mutat       Date:  2006-12       Impact factor: 4.878

8.  Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma.

Authors:  Lidia García-Colmenero; Jéssica González; Juan Sandoval; Yolanda Guillén; Angel Diaz-Lagares; Evelyn Andrades; Arnau Iglesias; Lara Nonell; Ramon Maria Pujol; Anna Bigas; Lluís Espinosa; Fernando Gallardo
Journal:  Cells       Date:  2020-12-15       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.